Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells.
about
The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cellsHighly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques.Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes.Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumorsOncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo.Virotherapy of neuroendocrine tumors.Targeting the somatostatin receptor in pituitary and neuroendocrine tumors.Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors.New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial.Update in the Therapy of Advanced Neuroendocrine Tumors.
P2860
Q28484664-799E5582-7A51-4DCD-8120-A3F30C968054Q34486159-B3795CDF-8A50-4129-BE71-1C5E5630204BQ34553261-401F0381-CACC-42F9-9750-A23F525204E3Q35288725-4E46572D-3DC2-4E33-9866-7A2A04901FD7Q35599319-D00AA073-B040-476E-858E-6417799DF843Q37325067-1A5C42C5-713A-46F9-BB50-9B92B6F17904Q37679277-02F67F95-CE07-4D75-9141-9E109834C5F2Q37989391-98155F4F-D9FA-4B11-87BE-EB294E4E9802Q38132768-6D7430E5-1860-49D0-8342-6DE8D467087EQ38264652-59112BF1-9415-474E-91AA-5AE93E6ABF04Q39347239-F49BA89A-CC59-4428-8013-F507E2C5FEFAQ47934716-DF581116-F227-47CE-9579-80D4B71AAA15Q48319014-DA1DE779-C6B3-4D0C-A950-493745C52E07Q49970741-AFB079A9-DECF-49E8-ACDD-1ADAEE10CF89
P2860
Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@ast
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@en
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@nl
type
label
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@ast
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@en
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@nl
prefLabel
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@ast
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@en
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@nl
P2093
P2860
P356
P1433
P1476
Oncolytic adenovirus modified ...... of neuroendocrine tumor cells.
@en
P2093
G Åkerström
T Hakkarainen
V Giandomenico
P2860
P2888
P304
P356
10.1038/GT.2011.54
P50
P577
2011-04-14T00:00:00Z